West Lafayette, IN, United States of America

Frank Brown, Jr


Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 13(Granted Patents)


Location History:

  • Indianapolis, IN (US) (1992)
  • West Lafayette, IN (US) (1994 - 2003)

Company Filing History:


Years Active: 1992-2003

Loading Chart...
3 patents (USPTO):Explore Patents

Title: **Frank Brown, Jr.: Pioneer in Pharmaceutical Innovations from West Lafayette, IN**

Introduction

Frank Brown, Jr. is an accomplished inventor based in West Lafayette, Indiana, recognized for his significant contributions to the field of pharmaceuticals. With a remarkable portfolio of three patents, his innovative approaches address critical challenges in drug formulation and development.

Latest Patents

One of Frank Brown Jr.'s latest patents focuses on a "Process for preparing pharmaceutical bulk material having uniform dissolution." This invention provides a method for creating cefaclor crystalline bulk material, achieving a dissolution rate of ≥80% in water within 30 minutes. The process includes reducing the water content of cefaclor dihydrates and allows for controlled rehydration, maintaining the desired dissolution rate. Additionally, another one of his patents outlines a "Process for preparing 7-substituted-amino-3-hydroxy-3-cephem-4-protected," which involves the conversion of a 4-chlorosulfonyl azetidinone to a 3-hydroxy-3-cephem-sulfoxide ester through an ozonolysis process using a tin-containing Lewis acid-type Fiedel-Crafts catalyst.

Career Highlights

Frank Brown, Jr. is part of Eli Lilly and Company, a leading global pharmaceutical company known for its innovative products. His work contributes directly to advancing pharmaceutical science and improving patient care through more effective drug formulations.

Collaborations

Throughout his career, Frank has collaborated with esteemed colleagues, notably Francis O Ginah and Leonard Larry Winneroski, Jr. These partnerships have facilitated innovative research and development efforts, further enhancing the company's capabilities in the pharmaceutical sector.

Conclusion

In conclusion, Frank Brown, Jr. stands as a prominent figure in the field of pharmaceutical inventions. His dedication to improving drug formulation processes and his collaborative spirit exemplify the essence of innovation in the pharmaceutical industry. With a solid foundation of patents and a successful career at Eli Lilly and Company, he continues to be an inspiration for future inventors and scientists.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…